---
figid: PMC6478763__fonc-09-00268-g0001
figtitle: Mechanisms supporting BRAF inhibitor resistance in melanoma
organisms:
- Homo sapiens
- Mus musculus
organisms_ner:
- Mus musculus
- Homo sapiens
- Danio rerio
pmcid: PMC6478763
filename: fonc-09-00268-g0001.jpg
figlink: /pmc/articles/PMC6478763/figure/F1/
number: F1
caption: Mechanisms supporting BRAF inhibitor resistance in melanoma. Receptor tyrosine
  kinases (RTK) include AXL receptor tyrosine kinase (AXL), epidermal growth factor
  receptor (EGFR), fibroblast growth factor receptor 1 (FGFR1), fibroblast growth
  factor receptor 3 (FGFR3), platelet-derived growth factor receptor beta (PDGFRB),
  MET proto-oncogene receptor tyrosine kinase (MET), and KIT proto-oncogene receptor
  tyrosine kinase (KIT). Growth factors (GF) correspond to the specific receptor tyrosine
  kinase. The MAPK/Erk pathway includes the Ras GTPases (N/K/HRAS), Serine/threonine-protein
  kinase B-raf (BRAF), RAF proto-oncogene serine/threonine-protein kinase (CRAF),
  mitogen-activated and extracellular signal-regulated kinase kinase 1 or 2 (MEK1/2),
  extracellular signal-regulated kinase 1 or 2 (ERK1/2), cancer Osaka thyroid (COT),
  and dual specificity protein phosphatase 4 (DUSP4). The PI3K/Akt pathway includes
  phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha (PIK3CA),
  phosphatidylinositol 3-kinase regulatory subunit 1 or 2 (PIK3R1/2), phosphatidylinositol
  4,5-bisphosphate (PIP2), phosphatidylinositol 3,4,5-trisphosphate (PIP3), phosphatase
  and tensin homolog (PTEN), AKT serine/threonine kinase 1 or 2 (AKT1/2), mammalian
  target of rapamycin complex 1 (mTORC1). Src signaling factors include SRC proto-oncogene
  non-receptor tyrosine kinase (SRC) and focal adhesion kinase 1 (FAK1). Transcription
  factors include signal transducer and activator of transcription 3 (STAT3), TEA
  domain transcription factor protein family (TEAD), activator protein 1 complex (AP-1),
  Jun proto-oncogene AP-1 transcription factor subunit (JUN), SRY-box 10 (SOX10),
  melanocyte inducing transcription factor (MITF), cyclic AMP responsive element binding
  protein family (CREB), FOS like 1 AP-1 transcription factor subunit (FOSL1), GLI
  family zinc finger 1 or 2 (GLI1/2), transforming growth factor beta (TGFβ), SMAD
  family member 3 (SMAD3). Cell cycle regulators included cyclin D1 (CCND1), cyclin
  dependent kinase 4 or 6 (CDK4/6). Non-canonical Wnt signaling mediators include
  receptor like tyrosine kinase (RYK), frizzled class receptor 7 (FZD7), and Wnt family
  member 5A (WNT5A).
papertitle: Diverse Mechanisms of BRAF Inhibitor Resistance in Melanoma Identified
  in Clinical and Preclinical Studies.
reftext: Stephen A. Luebker, et al. Front Oncol. 2019;9:268.
year: '2019'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.948003
figid_alias: PMC6478763__F1
figtype: Figure
redirect_from: /figures/PMC6478763__F1
ndex: 5bc45b4f-dec5-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6478763__fonc-09-00268-g0001.html
  '@type': Dataset
  description: Mechanisms supporting BRAF inhibitor resistance in melanoma. Receptor
    tyrosine kinases (RTK) include AXL receptor tyrosine kinase (AXL), epidermal growth
    factor receptor (EGFR), fibroblast growth factor receptor 1 (FGFR1), fibroblast
    growth factor receptor 3 (FGFR3), platelet-derived growth factor receptor beta
    (PDGFRB), MET proto-oncogene receptor tyrosine kinase (MET), and KIT proto-oncogene
    receptor tyrosine kinase (KIT). Growth factors (GF) correspond to the specific
    receptor tyrosine kinase. The MAPK/Erk pathway includes the Ras GTPases (N/K/HRAS),
    Serine/threonine-protein kinase B-raf (BRAF), RAF proto-oncogene serine/threonine-protein
    kinase (CRAF), mitogen-activated and extracellular signal-regulated kinase kinase
    1 or 2 (MEK1/2), extracellular signal-regulated kinase 1 or 2 (ERK1/2), cancer
    Osaka thyroid (COT), and dual specificity protein phosphatase 4 (DUSP4). The PI3K/Akt
    pathway includes phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit
    alpha (PIK3CA), phosphatidylinositol 3-kinase regulatory subunit 1 or 2 (PIK3R1/2),
    phosphatidylinositol 4,5-bisphosphate (PIP2), phosphatidylinositol 3,4,5-trisphosphate
    (PIP3), phosphatase and tensin homolog (PTEN), AKT serine/threonine kinase 1 or
    2 (AKT1/2), mammalian target of rapamycin complex 1 (mTORC1). Src signaling factors
    include SRC proto-oncogene non-receptor tyrosine kinase (SRC) and focal adhesion
    kinase 1 (FAK1). Transcription factors include signal transducer and activator
    of transcription 3 (STAT3), TEA domain transcription factor protein family (TEAD),
    activator protein 1 complex (AP-1), Jun proto-oncogene AP-1 transcription factor
    subunit (JUN), SRY-box 10 (SOX10), melanocyte inducing transcription factor (MITF),
    cyclic AMP responsive element binding protein family (CREB), FOS like 1 AP-1 transcription
    factor subunit (FOSL1), GLI family zinc finger 1 or 2 (GLI1/2), transforming growth
    factor beta (TGFβ), SMAD family member 3 (SMAD3). Cell cycle regulators included
    cyclin D1 (CCND1), cyclin dependent kinase 4 or 6 (CDK4/6). Non-canonical Wnt
    signaling mediators include receptor like tyrosine kinase (RYK), frizzled class
    receptor 7 (FZD7), and Wnt family member 5A (WNT5A).
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Fzd7
  - Ryk
  - Nras
  - Kras
  - Pik3ca
  - Pik3r1
  - Hras
  - Src
  - Braf
  - Braf-rs1
  - Raf1
  - Akt1
  - Akt3
  - Map3k8
  - Mapk3
  - Mapk1
  - Dusp4
  - Ccnd1
  - Sox10
  - Creb1
  - Fosl1
  - Jun
  - Ddx50
  - Tgfb1
  - Ltbp1
  - Stat3
  - Smad3
  - Mpeg1
  - Pkm
  - Prok2
  - Prickle2
  - Map2k1
  - Map2k2
  - Mitf
  - Tff3
  - Naip3
  - FZD7
  - RYK
  - NRAS
  - KRAS
  - PIK3CA
  - PIK3R1
  - HRAS
  - SRC
  - FGR
  - FYN
  - YES1
  - ACTA1
  - ACTA2
  - ACTB
  - ACTC1
  - ACTG1
  - ACTG2
  - BRAF
  - RAF1
  - PTK2
  - AKT1
  - AKT3
  - MAP3K8
  - CROT
  - MAPK3
  - MAPK1
  - DUSP4
  - MTOR
  - RPTOR
  - CCND1
  - SOX10
  - CREB1
  - CREB3
  - CREB5
  - CREB3L1
  - CREB3L2
  - CREB3L3
  - CREB3L4
  - CREM
  - ATF1
  - ATF2
  - FOSL1
  - JUN
  - JUNB
  - JUND
  - FOS
  - FOSB
  - DDX50
  - TEAD1
  - TEAD2
  - TEAD3
  - TEAD4
  - TGFB1
  - TGFB2
  - TGFB3
  - STAT3
  - SMAD3
  - MPEG1
  - PROK2
  - MAP2K1
  - MAP2K2
  - MITF
  - ryk
  - nras
  - kras
  - pik3ca
  - pik3r1
  - hrasa
  - src
  - braf
  - si:dkey-222f8.3
  - raf1a
  - akt1
  - akt3a
  - akt3b
  - mapk3
  - dusp4
  - ccnd1
  - sox10
  - fosl1a
  - jun
  - stat3
  - smad3a
  - prickle2b
  - map2k1
  - map2k2a
  - Cancer
  - Cardiomyopathy
  - Noonan syndrome
---
